The overall aim is study of the role of growth factors in colonocyte differentiation using the cell bank developed by this laboratory from one parental line. These include colon carcinoma cell lines permanently committed to enterocytic, fluid-transporting differentiation, HD3, HD4, and U4H, one enterocytic precursor cell line U4, and one line blocked in enterocytic maturation, HI1. All of these cell lines exhibit autocrine negative growth regulation by TGFbl. A second group of cell lines include those committed to goblet cell differentiation, HD6 and HD8, which display no modulation by TGFbl. The third group contains multilayered cell lines resistant to differentiation by HMBA, U9 and HP1, which utilize TGFbl as an autocrine positive growth regulator. It will be determined whether cells committed to enterocytic differentia- tion, HD3, HD4 and U4H, respond by growth inhibition to TGFbl through hypophosphorylation of the retinoblastoma gene product and where this occurs during the cell cycle and whether TGFbl-resistant cell lines maturing to goblet cells, HD6 and HD8, have lost TGFbl receptors. Whether differentiation interrupts a TGFalpha autocrine growth stimula- tory loop will be studied by comparing expression of both the ligand and receptor in differentiated and undifferentiated cells. The mechanism for loss of mitogenic response to basic FGF by differentiated colon carcinoma cells and whether autocrine FGF pathways exist in undifferentiated lines will be determined. Three possible indirect mechanisms for TGFbl-stimulation of growth of undifferentiated colon carcinoma lines will be examined. The effect of a transfected activated v-H-ras gene on goblet cell and enterocytic differentiation will be examined as will be the necessity of cell to cell contact through the L-CAM uvomorulin for enterocytic and goblet cell differentiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA045783-06
Application #
2092009
Study Section
Pathology B Study Section (PTHB)
Project Start
1987-07-01
Project End
1996-02-29
Budget Start
1994-03-01
Budget End
1995-02-28
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Yan, Z; Chen, M; Perucho, M et al. (1997) Oncogenic Ki-ras but not oncogenic Ha-ras blocks integrin beta1-chain maturation in colon epithelial cells. J Biol Chem 272:30928-36
Yan, Z; Deng, X; Chen, M et al. (1997) Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells. J Biol Chem 272:27902-7
Sauma, S; Yan, Z; Ohno, S et al. (1996) Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells. Cell Growth Differ 7:587-94
Sauma, S; Friedman, E (1996) Increased expression of protein kinase C beta activates ERK3. J Biol Chem 271:11422-6
Huang, F; Sauma, S; Yan, Z et al. (1995) Colon absorptive epithelial cells lose proliferative response to TGF alpha as they differentiate. Exp Cell Res 219:8-14
Hsu, S; Huang, F; Friedman, E (1995) Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J Cell Physiol 165:239-45
Friedman, E; Gold, L I; Klimstra, D et al. (1995) High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4:549-54
Hsu, S; Huang, F; Ossowski, L et al. (1995) Colon carcinoma cells with inactive nm23 show increased motility and response to motility factors. Carcinogenesis 16:2259-62
Huang, F; Newman, E; Theodorescu, D et al. (1995) Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Cell Growth Differ 6:1635-42
Sauma, S; Huang, F; Winawer, S et al. (1995) Colon goblet cells lose proliferative response to TGF alpha as they differentiate. Int J Cancer 61:848-53

Showing the most recent 10 out of 19 publications